EMEA-003386-PIP01-22 - paediatric investigation plan
taldefgrobep alfa
PIPHuman
Key facts
- Active Substance
- taldefgrobep alfa
- Decision number
- P/0537/2023
- PIP number
- EMEA-003386-PIP01-22
- Pharmaceutical form(s)
- Concentrate for solution for injection/infusion
- Condition(s) / indication(s)
- Treatment of spinal muscular atrophy
- Route(s) of administration
- Subcutaneous use
- Contact for public enquiries
Biohaven Bioscience Ireland Limited
E-mail: medinfo@biohavenpharma.com
Tel. +1 2034040410- Decision type
- P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
- Decision date